{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:50:52Z","timestamp":1794891052890,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51773050"],"award-info":[{"award-number":["51773050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51903067"],"award-info":[{"award-number":["51903067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The main hallmark of myocardial substrate metabolism in cardiac hypertrophy or heart failure is a shift from fatty acid oxidation to greater reliance on glycolysis. However, the close correlation between glycolysis and fatty acid oxidation and underlying mechanism by which causes cardiac pathological remodelling remain unclear. We confirm that KLF7 simultaneously targets the rate-limiting enzyme of glycolysis, phosphofructokinase-1, liver, and long-chain acyl-CoA dehydrogenase, a key enzyme for fatty acid oxidation. Cardiac-specific knockout and overexpression KLF7 induce adult concentric hypertrophy and infant eccentric hypertrophy by regulating glycolysis and fatty acid oxidation fluxes in male mice, respectively. Furthermore, cardiac-specific knockdown phosphofructokinase-1, liver or overexpression long-chain acyl-CoA dehydrogenase partially rescues the cardiac hypertrophy in adult male KLF7 deficient mice. Here we show that the KLF7\/PFKL\/ACADL axis is a critical regulatory mechanism and may provide insight into viable therapeutic concepts aimed at the modulation of cardiac metabolic balance in hypertrophied and failing heart.<\/jats:p>","DOI":"10.1038\/s41467-023-36712-9","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T14:01:38Z","timestamp":1676988098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The KLF7\/PFKL\/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Cao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4958-4118","authenticated-orcid":false,"given":"Weiming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"36712_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","volume":"142","author":"A Miron","year":"2020","unstructured":"Miron, A. et al. A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. Circulation 142, 217\u2013229 (2020).","journal-title":"Circulation"},{"key":"36712_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","volume":"3","author":"S Stewart","year":"2001","unstructured":"Stewart, S., Macintyre, K., Hole, D. J., Capewell, S. & Mcmurray, J. More \u2018malignant\u2019 than cancer? five-year survival following a first admission for heart failure. Eur. J. Heart Fail. 3, 315\u2013322 (2001).","journal-title":"Eur. J. Heart Fail."},{"key":"36712_CR3","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen, A., Rutten, F. H., Mosterd, A. & Hoes, A. W. Epidemiology of heart failure. Eur. J. Heart Fail 22, 1342\u20131356 (2020).","journal-title":"Eur. J. Heart Fail"},{"key":"36712_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2025797","volume":"384","author":"JR Teerlink","year":"2021","unstructured":"Teerlink, J. R. et al. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure. N. Engl. J. Med. 384, 105\u2013116 (2021).","journal-title":"N. Engl. J. Med."},{"key":"36712_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","volume":"121","author":"TM Lee","year":"2017","unstructured":"Lee, T. M. et al. Pediatric cardiomyopathies. Circ. Res. 121, 855\u2013873 (2017).","journal-title":"Circ. Res."},{"key":"36712_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2007.06.007","volume":"6","author":"WA Alaynick","year":"2007","unstructured":"Alaynick, W. A. et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 6, 13\u201324 (2007).","journal-title":"Cell Metab."},{"key":"36712_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero, E. & Maack, C. Metabolic remodelling in heart failure. Nat. Rev. Cardiol. 15, 457\u2013470 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"36712_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","volume":"126","author":"J Ritterhoff","year":"2020","unstructured":"Ritterhoff, J. et al. Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis. Circ. Res. 126, 182\u2013196 (2020).","journal-title":"Circ. Res."},{"key":"36712_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","volume":"123","author":"AA Gibb","year":"2018","unstructured":"Gibb, A. A. & Hill, B. G. Metabolic coordination of physiological and pathological cardiac remodeling. Circ. Res. 123, 107\u2013128 (2018).","journal-title":"Circ. Res."},{"key":"36712_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/FJC.0b013e3181e74a14","volume":"56","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D. & Jaswal, J. S. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J. Cardiovas. Pharmacol. 56, 130\u2013140 (2010).","journal-title":"J. Cardiovas. Pharmacol."},{"key":"36712_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","volume":"113","author":"SC Kolwicz Jr.","year":"2013","unstructured":"Kolwicz, S. C. Jr., Purohit, S. & Tian, R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ. Res. 113, 603\u2013616 (2013).","journal-title":"Circ. Res."},{"key":"36712_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff, J. & Tian, R. Metabolism in cardiomyopathy: every substrate matters. Cardiovasc. Res. 113, 411\u2013421 (2017).","journal-title":"Cardiovasc. Res."},{"key":"36712_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer, S. The failing heart-an engine out of fuel. N. Engl. J. Med. 356, 1140\u20131151 (2007).","journal-title":"N. Engl. J. Med."},{"key":"36712_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","volume":"40","author":"VG D\u00e1vila-Rom\u00e1n","year":"2002","unstructured":"D\u00e1vila-Rom\u00e1n, V. G. et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 40, 271\u2013277 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"36712_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley, W. C., Recchia, F. A. & Lopaschuk, G. D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093\u20131129 (2005).","journal-title":"Physiol. Rev."},{"key":"36712_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/jmcc.1994.1008","volume":"26","author":"PM Buttrick","year":"1994","unstructured":"Buttrick, P. M., Kaplan, M., Leinwand, L. A. & Scheuer, J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J. Mol. Cell. Cardiol. 26, 61\u201367 (1994).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"36712_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/01.HYP.0000144292.69599.0c","volume":"44","author":"L Nascimben","year":"2004","unstructured":"Nascimben, L. et al. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 44, 662\u2013667 (2004).","journal-title":"Hypertension"},{"key":"36712_CR18","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","volume":"94","author":"MN Sack","year":"1996","unstructured":"Sack, M. N. et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94, 2837\u20132842 (1996).","journal-title":"Circulation"},{"key":"36712_CR19","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/nm1211-1693c","volume":"17","author":"X Cao","year":"2011","unstructured":"Cao, X. Erratum: Corrigendum: Targeting osteoclast-osteoblast communication. Nat. Med. 17, 1693\u20131693 (2011).","journal-title":"Nat. Med."},{"key":"36712_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature09783","volume":"469","author":"EM Small","year":"2011","unstructured":"Small, E. M. & Olson, E. N. Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336\u2013342 (2011).","journal-title":"Nature"},{"key":"36712_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nm.3866","volume":"21","author":"LS Shankman","year":"2015","unstructured":"Shankman, L. S. et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat. Med. 21, 628\u2013637 (2015).","journal-title":"Nat. Med."},{"key":"36712_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.abe2762","volume":"372","author":"M Ogawa","year":"2021","unstructured":"Ogawa, M. et al. Kr\u00fcppel-like factor 1 is a core cardiomyogenic trigger in zebrafish. Science 372, 201\u2013205 (2021).","journal-title":"Science"},{"key":"36712_CR23","doi-asserted-by":"crossref","unstructured":"Fan, L. et al. Muscle Kruppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis. J. Clin. Invest. 131, e139496 (2021).","DOI":"10.1172\/JCI139496"},{"key":"36712_CR24","doi-asserted-by":"crossref","unstructured":"Montaigne, D., Butruille, L. & Staels, B. PPAR control of metabolism and cardiovascular functions. Nat. Rev. Cardiol. 18, 809\u2013823 (2021).","DOI":"10.1038\/s41569-021-00569-6"},{"key":"36712_CR25","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.jacc.2019.07.076","volume":"74","author":"C Noack","year":"2019","unstructured":"Noack, C. et al. KLF15-Wnt-dependent cardiac reprogramming up-regulates SHISA3 in the mammalian heart. J. Am. Coll. Cardiol. 74, 1804\u20131819 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"36712_CR26","doi-asserted-by":"publisher","first-page":"26ra26","DOI":"10.1126\/scitranslmed.3000502","volume":"2","author":"SM Haldar","year":"2010","unstructured":"Haldar, S. M. et al. Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci. Transl. Med. 2, 26ra26 (2010).","journal-title":"Sci. Transl. Med."},{"key":"36712_CR27","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1073\/pnas.0701981104","volume":"104","author":"S Fisch","year":"2007","unstructured":"Fisch, S. et al. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc. Natl Acad. Sci. 104, 7074\u20137079 (2007).","journal-title":"Proc. Natl Acad. Sci."},{"key":"36712_CR28","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1074\/jbc.M113.531384","volume":"9","author":"DA Prosdocimo","year":"2014","unstructured":"Prosdocimo, D. A. et al. Kruppel-like factor 15 is a critical regulator of cardiac lipid metabolism. J. Biol. Chem. 9, 5914\u20135924 (2014).","journal-title":"J. Biol. Chem."},{"key":"36712_CR29","doi-asserted-by":"publisher","first-page":"e139496","DOI":"10.1172\/JCI139496","volume":"4","author":"L Fan","year":"2021","unstructured":"Fan, L. et al. Muscle Kr\u00fcppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis. J. Clin. Invest. 4, e139496 (2021).","journal-title":"J. Clin. Invest."},{"key":"36712_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/01.RES.0000185833.42544.06","volume":"97","author":"J Wang","year":"2005","unstructured":"Wang, J. et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ. Res. 97, 821\u2013828 (2005).","journal-title":"Circ. Res."},{"key":"36712_CR31","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nm738","volume":"8","author":"T Shindo","year":"2002","unstructured":"Shindo, T. et al. Kr\u00fcppel-like zinc-finger transcription factor KLF5\/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8, 856\u2013863 (2002).","journal-title":"Nat. Med."},{"key":"36712_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.yjmcc.2010.04.008","volume":"49","author":"XD Liao","year":"2010","unstructured":"Liao, X. D. et al. Kr\u00fcppel-like factor 4 regulates pressure-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 49, 334\u2013338 (2010).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"36712_CR33","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/CIRCRESAHA.108.176974","volume":"102","author":"T Yoshida","year":"2008","unstructured":"Yoshida, T., Kaestner, K. H. & Owens, G. K. Conditional deletion of kr\u00fcppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ. Res. 102, 1548\u20131557 (2008).","journal-title":"Circ. Res."},{"key":"36712_CR34","doi-asserted-by":"publisher","first-page":"26107","DOI":"10.1074\/jbc.M114.582809","volume":"289","author":"T Yoshida","year":"2014","unstructured":"Yoshida, T., Yamashita, M., Horimai, C. & Hayashi, M. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. J. Biol. Chem. 289, 26107\u201326118 (2014).","journal-title":"J. Biol. Chem."},{"key":"36712_CR35","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1172\/JCI79964","volume":"9","author":"XD Liao","year":"2015","unstructured":"Liao, X. D. et al. Kruppel-like factor 4 is critical for transcriptional control of cardiac mitochondrial homeostasis. J. Clin. Invest. 9, 3461\u20133476 (2015).","journal-title":"J. Clin. Invest."},{"key":"36712_CR36","doi-asserted-by":"publisher","first-page":"e57193","DOI":"10.1371\/journal.pone.0057193","volume":"8","author":"RK Vangala","year":"2013","unstructured":"Vangala, R. K. et al. Integrative bioinformatics analysis of genomic and proteomic approaches to understand the transcriptional regulatory program in coronary artery disease pathways. PLoS ONE 8, e57193 (2013).","journal-title":"PLoS ONE"},{"key":"36712_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00125-005-1797-0","volume":"48","author":"A Kanazawa","year":"2005","unstructured":"Kanazawa, A. et al. Single nucleotide polymorphisms in the gene encoding Kruppel-like factor 7 are associated with type 2 diabetes. Diabetologia 48, 1315\u20131322 (2005).","journal-title":"Diabetologia"},{"key":"36712_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1210\/er.2018-00151","volume":"40","author":"PN Hsieh","year":"2019","unstructured":"Hsieh, P. N., Fan, L., Sweet, D. R. & Jain, M. K. The Kruppel-like factors and control of energy homeostasis. Endocr. Rev. 40, 137\u2013152 (2019).","journal-title":"Endocr. Rev."},{"key":"36712_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jacbts.2017.09.001","volume":"3","author":"NM Pollak","year":"2018","unstructured":"Pollak, N. M., Hoffman, M., Goldberg, I. J. & Drosatos, K. Kruppel-like factors: crippling and un-crippling metabolic pathways. JACC Basic Transl. Sci. 3, 132\u2013156 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"36712_CR40","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","volume":"141","author":"Z Ren","year":"2020","unstructured":"Ren, Z. et al. Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy. Circulation 141, 1704\u20131719 (2020).","journal-title":"Circulation"},{"key":"36712_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07127-8","volume":"9","author":"L Li","year":"2018","unstructured":"Li, L. et al. TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation. Nat. Commun. 9, 4683 (2018).","journal-title":"Nat. Commun."},{"key":"36712_CR42","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/labinvest.2009.86","volume":"89","author":"KB Cox","year":"2009","unstructured":"Cox, K. B. et al. Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency. Lab Invest. 89, 1348\u20131354 (2009).","journal-title":"Lab Invest."},{"key":"36712_CR43","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.ultrasmedbio.2018.05.021","volume":"44","author":"RA Mukaddim","year":"2018","unstructured":"Mukaddim, R. A., Rodgers, A., Hacker, T. A., Heinmiller, A. & Varghese, T. Real-time in vivo photoacoustic imaging in the assessment of myocardial dynamics in murine model of myocardial ischemia. Ultrasound Med. Biol. 44, 2155\u20132164 (2018).","journal-title":"Ultrasound Med. Biol."},{"key":"36712_CR44","doi-asserted-by":"publisher","first-page":"835985","DOI":"10.1155\/2015\/835985","volume":"2015","author":"CJ Pol","year":"2015","unstructured":"Pol, C. J., Lieu, M. & Drosatos, K. PPARs: protectors or opponents of myocardial function? PPAR Res. 2015, 835985 (2015).","journal-title":"PPAR Res."},{"key":"36712_CR45","doi-asserted-by":"publisher","first-page":"201625","DOI":"10.1155\/2015\/201625","volume":"2015","author":"DA Prosdocimo","year":"2015","unstructured":"Prosdocimo, D. A. et al. KLF15 and PPARalpha cooperate to regulate cardiomyocyte lipid gene expression and oxidation. PPAR Res. 2015, 201625 (2015).","journal-title":"PPAR Res."},{"key":"36712_CR46","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nm1756","volume":"14","author":"Y Oishi","year":"2008","unstructured":"Oishi, Y. et al. SUMOylation of Kruppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta. Nat. Med. 14, 656\u2013666 (2008).","journal-title":"Nat. Med."},{"key":"36712_CR47","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1161\/CIRCULATIONAHA.117.028274","volume":"136","author":"AA Gibb","year":"2017","unstructured":"Gibb, A. A. et al. Exercise-induced changes in glucose metabolism promote physiological cardiac growth. Circulation 136, 2144\u20132157 (2017).","journal-title":"Circulation"},{"key":"36712_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","volume":"116","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian, H., Frenneaux, M. P. & Opie, L. H. Metabolic mechanisms in heart failure. Circulation 116, 434\u2013448 (2007).","journal-title":"Circulation"},{"key":"36712_CR49","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","volume":"6","author":"L Zhang","year":"2013","unstructured":"Zhang, L. et al. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ. Heart Fail. 6, 1039\u20131048 (2013).","journal-title":"Circ. Heart Fail."},{"key":"36712_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","volume":"33","author":"AA Cluntun","year":"2021","unstructured":"Cluntun, A. A. et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 33, 629\u2013648.e610 (2021).","journal-title":"Cell Metab."},{"key":"36712_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/cvr\/cvp414","volume":"86","author":"T Doenst","year":"2010","unstructured":"Doenst, T. et al. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload. Cardiovasc. Res. 86, 461\u2013470 (2010).","journal-title":"Cardiovasc. Res."},{"key":"36712_CR52","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s42255-020-00276-5","volume":"2","author":"M Fernandez-Caggiano","year":"2020","unstructured":"Fernandez-Caggiano, M. et al. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy. Nat. Metab. 2, 1223\u20131231 (2020).","journal-title":"Nat. Metab."},{"key":"36712_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/CIRCRESAHA.119.316358","volume":"2","author":"TR Matsuura","year":"2020","unstructured":"Matsuura, T. R., Leone, T. C. & Kelly, D. P. Fueling cardiac hypertrophy. Circ. Res. 2, 197\u2013199 (2020).","journal-title":"Circ. Res."},{"key":"36712_CR54","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","volume":"5","author":"L Zhang","year":"2013","unstructured":"Zhang, L. et al. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ. Heart Fail. 5, 1039\u20131048 (2013).","journal-title":"Circ. Heart Fail."},{"key":"36712_CR55","first-page":"461","volume":"3","author":"D Torsten","year":"2010","unstructured":"Torsten, D. et al. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload. Cardiovasc. Res. 3, 461\u2013470 (2010).","journal-title":"Cardiovasc. Res."},{"key":"36712_CR56","doi-asserted-by":"crossref","unstructured":"Arumugam, S. et al. Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach? Drug Discovery Today 21, 1003\u20131008 (2016).","DOI":"10.1016\/j.drudis.2016.02.010"},{"key":"36712_CR57","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","volume":"111","author":"SC Kolwicz","year":"2012","unstructured":"Kolwicz, S. C. et al. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ. Res. 111, 728\u2013738 (2012).","journal-title":"Circ. Res."},{"key":"36712_CR58","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41598-017-02360-5","volume":"7","author":"Zhiwei","year":"2017","unstructured":"Zhiwei et al. Astragaloside IV alleviates heart failure via activating PPAR\u03b1 to switch glycolysis to fatty acid \u03b2-oxidation. Sci. Rep. 7, 2691\u20132706 (2017).","journal-title":"Sci. Rep."},{"key":"36712_CR59","doi-asserted-by":"publisher","first-page":"e018298","DOI":"10.1161\/JAHA.120.018298","volume":"10","author":"X Li","year":"2021","unstructured":"Li, X. et al. Direct cardiac actions of the sodium glucose co-transporter 2 inhibitor empagliflozin improve myocardial oxidative phosphorylation and attenuate pressure-overload heart failure. J. Am. Heart Assoc. 10, e018298 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"36712_CR60","doi-asserted-by":"crossref","unstructured":"Ji, J. J. & Yao, Y. Kallistatin\/ serpina3c inhibits fibrosis after myocardial infarction by regulating glycolytic pathway. Eur. Heart J. 42, Supplement_1 (2021).","DOI":"10.1093\/eurheartj\/ehab724.0771"},{"key":"36712_CR61","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCRESAHA.115.304185","volume":"7","author":"N Biesemann","year":"2014","unstructured":"Biesemann, N. & Braun, T. Myostatin regulates energy homeostasis in the heart and prevents heart failure. Circ. Res. 7, 296\u2013310 (2014).","journal-title":"Circ. Res."},{"key":"36712_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41586-019-1667-4","volume":"575","author":"A Hoshino","year":"2019","unstructured":"Hoshino, A. et al. The ADP\/ATP translocase drives mitophagy independent of nucleotide exchange. Nature 575, 375\u2013379 (2019).","journal-title":"Nature"},{"key":"36712_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ng0398-231","volume":"18","author":"NG Larsson","year":"1998","unstructured":"Larsson, N. G., Wang, J., Wilhelmsson, H., Oldfors, A. & Clayton, D. A. Mitochondrial transcription factor a is necessary for mtdna maintance and embryogenesis in mice. Nat. Genet. 18, 231\u2013236 (1998).","journal-title":"Nat. Genet."},{"key":"36712_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-5793(93)81805-A","volume":"326","author":"M Horiuchi","year":"1993","unstructured":"Horiuchi, M. et al. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett. 326, 1\u20133 (1993).","journal-title":"FEBS Lett."},{"key":"36712_CR65","first-page":"92","volume":"1","author":"S Yoshihiro","year":"2003","unstructured":"Yoshihiro, S. et al. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder. Cardiovasc. Res. 1, 92\u2013100 (2003).","journal-title":"Cardiovasc. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36712-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36712-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36712-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T14:15:15Z","timestamp":1676988915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36712-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36712"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36712-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"959"}}